Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;38(5):1191-9.
doi: 10.1007/s11096-016-0352-z. Epub 2016 Jul 23.

Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness

Affiliations

Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness

Mediha Younas et al. Int J Clin Pharm. 2016 Oct.

Abstract

Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipolar affective disorder are frequently treated with antipsychotics. National guidance advises the use of shared decision-making (SDM) in antipsychotic prescribing. There is currently little data on the opinions of health professionals on the role of SDM. Objective To explore the views and experiences of UK mental health pharmacists regarding the use of SDM in antipsychotic prescribing in people diagnosed with SMI. Setting The study was conducted by interviewing secondary care mental health pharmacists in the UK to obtain qualitative data. Methods Semi-structured interviews were recorded. An inductive thematic analysis was conducted using the method of constant comparison. Main outcome measure Themes evolving from mental health pharmacists on SDM in relation to antipsychotic prescribing in people with SMI. Results Thirteen mental health pharmacists were interviewed. SDM was perceived to be linked to positive clinical outcomes including adherence, service user satisfaction and improved therapeutic relations. Despite more prescribers and service users supporting SDM, it was not seen as being practised as widely as it could be; this was attributed to a number of barriers, most predominantly issues surrounding service user's lacking capacity to engage in SDM and time pressures on clinical staff. The need for greater effort to work around the issues, engage service users and adopt a more inter-professional approach was conveyed. Conclusion The mental health pharmacists support SDM for antipsychotic prescribing, believing that it improves outcomes. However, barriers are seen to limit implementation. More research is needed into overcoming the barriers and measuring the benefits of SDM, along with exploring a more inter-professional approach to SDM.

Keywords: Antipsychotic prescribing; Mental health pharmacy; Shared decision making; United Kingdom.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest were identified.

Similar articles

Cited by

References

    1. Mental Health Foundation. What are mental health problems? n.d. http://www.mentalhealth.org.uk/help-information/an-introduction-to-menta.... Accessed 24 Nov 2015.
    1. Hafal. Mental Health in Wales. n.d. http://www.mentalhealthwales.net/mhw/whatis.php. Accessed 9 Oct 2015.
    1. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373:31–41. doi: 10.1016/S0140-6736(08)61764-X. - DOI - PubMed
    1. NICE. Clinical guidelines 76: medicines adherence involving patients in decisions about prescribed medications and supporting adherence available. 2009. http://www.nice.org.uk/guidance/cg76/chapter/introduction Accessed 4 Feb 2016.
    1. Nosé M, Barbui C, Gray R, Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta analysis. Br J Psychiatry. 2003;183:197–206. doi: 10.1192/bjp.183.3.197. - DOI - PubMed

Substances

LinkOut - more resources